CRISPR gene editing to help immune cells target and kill cancer
New Scientist - 06-Feb-2020First CRISPR cancer trial in the world publish its promising findings
Join the club for FREE to access the whole archive and other member benefits.
Magazine devoted to short articles about new scientific and technical developments
For almost a century, Science News journalists have covered advances in science, medicine and technology for the general public, including the 1925 Scopes “monkey” trial, the advent of the atomic age in 1945, the space race, and the revolution of genetic engineering from the discovery of DNA to today’s gene-editing technology.
We were founded as an independent nonprofit in 1921 by newspaper magnate E.W. Scripps and zoologist W.E. Ritter, who wanted to improve the quality and accuracy of science journalism. We remain true to that mission today.
We believe in the power of knowledge and the free flow of information to build informed, enlightened and engaged communities. Our mission is to provide independent, unbiased coverage of science and give people the tools to evaluate the news and the world around them.
Visit website: https://www.sciencenews.org/
Details last updated 04-Feb-2019
First CRISPR cancer trial in the world publish its promising findings